China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ)

CNY 45.31

(3.0%)

Market Cap (In CNY)

57.85 Billion

Revenue (In CNY)

24.73 Billion

Net Income (In CNY)

2.85 Billion

Avg. Volume

9.73 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
36.24-52.55
PE
17.23
EPS
2.63
Beta Value
0.411
ISIN
CNE0000011K8
CUSIP
-
CIK
-
Shares
1276760432.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Zheng Liang
Employee Count
-
Website
https://www.999.com.cn
Ipo Date
2000-03-09
Details
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough relieving, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. It sells its products under 999 family medicine brands, Sanjiuweitai series, 999 Ganmaoling series, 999 dermatitis series, and other products. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources (Holdings) Co., Ltd.